Recent Advances in Hybrid Imaging for Radiation Therapy Planning: The Cutting Edge.
In the past decade, there have been many contributions demonstrating the advantages of combining morphologic and molecular imaging, and with commercial PET/CT scanners emerging in the same time frame, PET/CT has already had a significant impact on patient management. Ultimately, molecular imaging-guided radiotherapy holds the promise of improved definition of tumor target volumes. Yet, despite considerable progress to date, challenges remain if the potential of PET/CT-guided radiotherapy treatment planning is to be fully exploited in clinics.